Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl4-treated rats

Journal of Medicinal Food

Volumn 18, Issue 3, 2015, Pages 290-298

  Clichici, Simona ^a   Olteanu, Diana ^a   Nagy, Andras Laszlo ^b   Oros, Adrian ^b   Filip, Adriana ^a   Mircea, Petru A ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

Author keywords

liver fibrosis; oxidative stress; Silymarin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; LACTIC ACID; SILYMARIN; SUNFLOWER OIL; ACTIN; ANTIOXIDANT; PLANT EXTRACT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOLYSIS; DISEASE SEVERITY; EVALUATION STUDY; FEEDING; KUPFFER CELL; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STELLATE CELL; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIVER; LIVER CIRRHOSIS; METABOLISM; PHYTOTHERAPY; RANDOMIZATION; SILYBUM MARIANUM; WISTAR RAT;

HELIANTHUS; RATTUS; RATTUS NORVEGICUS;

ACTINS; ANIMALS; ANTIOXIDANTS; CARBON TETRACHLORIDE; DRUG-INDUCED LIVER INJURY; HEPATIC STELLATE CELLS; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS; MALE; MILK THISTLE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS, WISTAR; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84924101723     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.0179     Document Type: Article

References (36)

1. Malhi H, Gores GJ. Mechanism of liver injury. In Schiff's Diseases of the liver, Vol.1. (Schiff ER, Sorrell MF, Maddrey WC, eds.). Lippincott Williams & Wilkins, Philadelphia, 2007, pp. 313-324
2. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-49082
3. Friedman SL. Hepatic fibrosis. In Schiff's Diseases of the Liver, Vol.1. (Schiff ER, Sorrell MF, Maddrey WC, eds.). Lippincott Williams & Wilkins, Philadelphia, 2007, pp. 395-410
4. Féher J, Lengyel G. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Curr Pharm Biotechnol 2012;13:210-217
5. Loguercio C, Festi D. Silybin and the liver: from basic research to clinical practice. World J gastroenterol 2011;17:2288-2301
6. Tsai JH, Liu JY, Wu TT, Ho PC, Huang CY, Shyu JC, Hsieh YS, Tsai CC, Liu YC. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. J Viral Hepat 2008;15:508-514
7. Shafik AN, Khodeir MM, Gouda NA, Mahmoud ME. Improved antifibrotic effect of a combination of verapamil and silymarin in rat-induced liver fibrosis. Arab J Gastroenterol 2011;12:143-149
8. Chen IS, Chen YC, Chou CH, Chuang RF, Sheen LY, Chiu CH. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. J Sci Food 2012;92:1441-1447
9. Muriel P, Moreno MG, Hernández Mdel C, Chávez E, Alcantar LK. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. Basic Clin Pharmacol Toxicol 2005;96:375-380
10. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001;15: 465-489
11. Trappoliere M, Caligiuri A, Schmid M, Bertolani C, Failli P, Vizzuti F, Novo E, di Manzano C, Marra F, Loguercio C, Pinzani M. Silybin, a component of silymarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol 2009;50:1102-1111
12. Clichici S, Catoi C, Mocan T, Filip A, Login C, Nagy A, Daicoviciu D, Decea N, Gherman C, Moldovan R, Muresan A. Noninvasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis. Acta Physiol Hung 2011;98: 195-204
13. Clichici S, Biris AR, Tabaran F, Filip A. Transient oxidative stress and inflammation after intraperitoneal administration of multiwalled carbon nanotubes functionalized with single strand DNA in rats. Toxicol Appl Pharmacol 2012;259:281-292
14. Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem 1978;24:58-73
15. Krieg AF, Rosenblum LJ, Henry JB. Lactate dehydrogenase isoenzymes a comparison of pyruvate-to-lactate and lactate-topyruvate assays. Clin Chem 1967;13:196-203
16. Olteanu D, Nagy A, Dudea M, Filip A, Muresxan A, Catoi C, Mircea PA. Hepatic and systemic effects of Rosuvastatin on an experimental model of bile duct ligation in rats. J Physiol Pharmacol 2012;63:483-496
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
18. Conti M, Moran PC, Levillain P. Improved fluorimetric determination of malondialdehyde. Clin Chem 1991;37:1273-1275
19. Reznick AZ, Packer L. Oxidative damage to proteins spectrophotometric method for carbonyl assay. Meth Enzymol 1994; 233:357-363
20. Vats P, Singh VK, Singh SN, Singh SB. Glutathione metabolism under high-altitude stress and effect of antioxidant supplementation. Aviat Space Environ Med 2008;79:1106-1111
21. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, Kaneko S. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007;46:1392-1403
22. Loguercio C, Andreone P, Brisc C, Chiaramonte M, De Sio I, Federico A, Floreani A, Freni MA, Grieco A, Lobello S, Milani S, Okolicsanyi L, Portincasa P, Smedile A, Spadaro A, Sporea I, Sorrentino P, Vecchione R, Del Vecchio Blanco C. Effect of silybin in patients with chronic hepatitis: preliminary results of a multicentre randomized contrlled trial vs placebo. Gastroenterology 2010;138 Suppl 1:8800
23. Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food 2013;16:778-784
24. Usha K, Hemalatha P. Hepatoprotective effect of hygrophila spinosa and cassia occidentalis on carbon tetrachloride induced liver damage in experimental rats. Indian J Clin Biochem 2007; 22:132-135
25. Urtasun R, Nieto N. Hepatic stellate cells and oxidative stress. Rev Esp Enferm Dig 2007;99:223-230
26. Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of Kupffer cells on stellate cells. Hepatology 2006;44:1487-1501
27. Lee KS, Lee SJ, Park HJ, Chung JP, Han KH, Chon CY, Lee SI, Moon YM. Oxidative stress effect on the activation of hepatic stellate cells. Yonsei Med J 2001;42:1-8
28. Yeshua H, Oren R. Non invasive assessment of liver fibrosis. Ann Transplant 2008;13:5-11
29. Shaker ME, Shiha GE, Ibrahim TM. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis. Eur J Pharmacol 2011;670:593-600
30. Ahmed AF, Mahmoud MF, Ouf MA, El-Fathaah EA. Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats. Ann Hepatol 2011;10:207-215
31. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 2006;124:491-504
32. Friedman SL. Mac the knife? Macrophages-the double-edged sword of hepatic fibrosis. J Clin Invest 2005;115:29-32
33. Paradis V, Mathurin P, Kollinger M, Imbert-Bismut F, Charlotte F, Piton A, Opolon P, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxidation in chronic hepatitis C. correlation with pathological features. J Clin Pathol 1997; 50:401-406
34. Nieto N, Friesdman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cellsy cytochrome P450 2E1-derived reactive oxygen species. Hepatology 2002;35: 62-73
35. Kim M, Yang SG, Kim JM, Lee JW, Kim YS, Lee JI. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med 2012;30:473-479
36. Hui CK, Belaye T,Montegrande K,Wright TL: A comparison in the progression of liver fibrosis in chronic hepatitisCbetween persistently normal and elevated transaminase. J Hepatol 2003;38:511-517